Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of mangalore
- PMID: 24392372
- PMCID: PMC3879894
- DOI: 10.7860/JCDR/2013/6298.3578
Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of mangalore
Abstract
Objective: The incidence of Candida has been on rise worldwide. Urinary tract infections (UTIs) as a result of Candida species are becoming, common in hospitalised patients. Clinicians face dilemma in differentiating colonization from true candiduria. The species identification of Candida is important, as non albicans Candida species are increasing in number and more resistant to antifungal drugs. The aim of the study was to find out the frequency of Candida among uropathogens, their speciation and to determine the susceptibilities to antifungal drugs of Candida species isolated from candiduria.
Material and methods: A total of 2900 urine samples were analysed in a tertiary care hospital. Candida species isolated from urine samples were subjected to speciation using CHROM agar and standard yeast identification protocol. Antifungal susceptibility testing for fluconazole, voriconazole, flucytosine, amphotericin B was carried out using VITEK-2 compact system of Biomerieux.
Result: A total of 66(2.27%) Candida species were isolated from 2900 urine samples. Among them non albicans Candida species were predominant (69.7%) compared to Candida albicans (30.3%). The Candida isolated were more susceptible to amphotericin B (91%) and flucytosine (82%) compared to voriconazole (72.72%) and fluconazole (66.66%).
Conclusion: The present study reiterates the prevalence of Candida species among UTIs and their antifungal susceptibility pattern. Prevalence of non albicans Candida was more than Candida albicans. Non albicans Candida species are more resistant to antifungal drugs compared to C.albicans. Therefore, the species identification of Candida isolates along with their antifungal susceptibility pattern can help the clinicians in better treating the patients with candiduria.
Keywords: Antifungal susceptibility testing; Candiduria; Non albicans Candida.
References
-
- Manisha J, Vinita D, Bibhabati M, Archana T, Poonam SL, Aradhana B. Candiduria in catheterized intensive care unit patients: Emerging microbiological trends. Ind. J.Path. Micro. 2011;54(3):552–55. - PubMed
-
- Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolate of Candida species determined by broth microdilution, disc diffusion and E test method: report from the ARTEMIS global antifungal susceptibility program 2001. J Clin Microbiol. 2003;41:1440–46. - PMC - PubMed
-
- Lundstrom T, Sobel J. Nosocomial candiduria: A review. Clin Infect Dis. 2001;32:1602–07. - PubMed
-
- Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalised patients. Clin Infect Dis. 2000;30:14–18. - PubMed
-
- Manjunath GN, Prakash R, Vamseedhar A, Kiran S. Changing trends in the spectrum of antimicrobial drug resistance pattern of uropathogens isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res. 2011;2(2):504–07.
LinkOut - more resources
Full Text Sources
Other Literature Sources